|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.80 SAR | +0.26% |
|
+1.99% | -7.46% |
| 08:36am | Avalon Pharma Posts Growth in H1 Net Profit, Revenue | MT |
| 07-17 | Derayah Financial Starts Avalon Pharma's Coverage at Buy | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.26% | +1.99% | -3.05% | +1.28% | -7.46% | -13.38% | - | - | - | 548M | |
| +0.73% | -2.28% | +2.23% | +5.69% | +13.71% | +22.59% | +68.46% | +149.04% | +134.81% | 48.95B | |
| +2.92% | +7.52% | +4.07% | +7.95% | +36.99% | +60.61% | +132.10% | +176.56% | +157.90% | 39.36B | |
| +1.73% | +1.23% | +0.83% | +8.80% | -1.77% | -0.15% | +21.32% | +62.90% | +177.27% | 12.39B | |
| -0.50% | +0.04% | -2.82% | +18.82% | +22.00% | +19.60% | +70.25% | +90.42% | +198.50% | 11.76B | |
| +1.91% | -0.38% | +0.58% | +7.17% | +28.82% | +30.75% | +134.53% | +138.81% | +347.01% | 9.14B | |
| +1.34% | +3.50% | -0.66% | -5.69% | +22.76% | +15.77% | +35.84% | +38.24% | +110.98% | 7.05B | |
| +1.80% | -4.64% | -4.29% | -0.72% | +7.87% | +37.05% | -13.97% | -5.16% | -18.66% | 6.86B | |
| +0.20% | +3.45% | -0.22% | -4.70% | +11.33% | +11.86% | +177.67% | +279.88% | +163.96% | 6.7B | |
| +0.79% | +3.84% | -14.30% | -33.03% | -30.68% | -29.57% | +15.81% | +24.82% | +21.68% | 5.67B | |
| +0.51% | +0.54% | +2.41% | +11.58% | +24.77% | +35.94% | +97.90% | +125.73% | +175.96% | 4.51B | |
| -0.09% | -0.15% | -6.31% | -0.18% | +26.53% | +28.48% | -23.41% | -16.42% | -60.78% | 4.02B | |
| +0.58% | -2.64% | +1.25% | +3.66% | +1.75% | -4.55% | +77.81% | +40.32% | - | 3.97B | |
| -0.44% | +4.84% | +4.21% | +16.26% | +38.02% | +35.13% | +668.91% | +291.93% | +118.14% | 3.43B | |
| +3.08% | +12.16% | +4.73% | +3.46% | -3.03% | -3.78% | +54.90% | +196.76% | +737.80% | 2.93B | |
| +0.37% | -0.98% | +0.12% | -6.18% | +2.61% | +14.19% | +67.26% | +19.27% | +79.18% | 2.77B | |
| -0.42% | +31.70% | -22.15% | -59.32% | -28.34% | -13.54% | +148.66% | +195.39% | +1,598.27% | 2.74B | |
| -1.91% | -10.55% | -6.31% | -17.60% | -21.14% | -39.97% | +35.42% | +60.67% | +8.96% | 2.69B | |
| +0.50% | +2.97% | -4.38% | -7.79% | -0.21% | -13.41% | +19.93% | - | - | 2.65B | |
| +1.66% | +3.52% | -12.28% | -12.62% | +7.96% | -49.48% | +47.90% | +53.39% | - | 2.41B | |
| Average | +0.76% | +2.12% | -2.82% | -3.16% | +7.62% | +7.21% | +96.70% | +106.81% | +246.94% | 9.03B | |
| Weighted average by Cap. | +1.27% | +0.38% | +0.19% | +3.20% | +16.49% | +24.25% | +90.42% | +128.14% | +176.22% |
- Stock Market
- Stocks
- 4016 Stock
- Sector Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
